# GRASS (Grass MATA MPL Real-world Assessment Study)

> **NCT07412990** · — · RECRUITING · sponsor: **Allergy Therapeutics** · enrollment: 1000 (estimated)

## Conditions studied

- Grass Pollen Allergy

## Interventions

- **DRUG:** Grassmuno®

## Key facts

- **NCT ID:** NCT07412990
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-11
- **Primary completion:** 2028-10-02
- **Final completion:** 2028-10-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07412990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07412990, "GRASS (Grass MATA MPL Real-world Assessment Study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07412990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*